Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Lentiviral-mediated BCL2 gene knockdown using comparative microRNA adaptive shRNAs.

Abdolhossein Zadeh B, Yavari K, Banan M, Fallah A, Nasehi L, Absalan M, Tavoosidana G.

Cell Mol Biol (Noisy-le-grand). 2018 Aug 30;64(11):25-30.

PMID:
30213285
2.

Effects of Ectoine on Behavior and Candidate Genes Expression in ICV-STZ Rat Model of Sporadic Alzheimer's Disease.

Bazazzadegan N, Dehghan Shasaltaneh M, Saliminejad K, Kamali K, Banan M, Nazari R, Riazi GH, Khorram Khorshid HR.

Adv Pharm Bull. 2017 Dec;7(4):629-636. doi: 10.15171/apb.2017.075. Epub 2017 Dec 5.

3.

Effects of Herbal Compound (IMOD) on Behavior and Expression of Alzheimer's Disease Related Genes in Streptozotocin-Rat Model of Sporadic Alzheimer's Disease.

Bazazzadegan N, Dehghan Shasaltaneh M, Saliminejad K, Kamali K, Banan M, Khorram Khorshid HR.

Adv Pharm Bull. 2017 Sep;7(3):491-494. doi: 10.15171/apb.2017.060. Epub 2017 Sep 25.

4.

The Effects of Melilotus officinalis Extract on Expression of Daxx, Nfkb and Vegf Genes in the Streptozotocin-Induced Rat Model of Sporadic Alzheimer's Disease.

Bazazzadegan N, Dehghan Shasaltaneh M, Saliminejad K, Kamali K, Banan M, Khorram Khorshid HR.

Avicenna J Med Biotechnol. 2017 Jul-Sep;9(3):133-137.

5.

An enhancer haplotype may influence BCL11A expression levels and the response to hydroxyurea in β-thalassemia patients.

Maroofi N, Azarkeivan A, Banihashemi S, Mohammadparast S, Aghajanirefah A, Banan M.

Pharmacogenomics. 2017 Jul;18(10):995-967. doi: 10.2217/pgs-2017-0019. Epub 2017 Jun 22.

PMID:
28639471
6.

Cyclic AMP-Induced p53 Destabilization is Independent of CREB in Pre-B Acute Lymphoblastic Leukemia Cells.

Manafi Shabestari R, Safa M, Banan M, Kazemi A.

Int J Mol Cell Med. 2016 Fall;5(4):220-228. Epub 2017 Jan 18.

7.

CREB knockdown inhibits growth and induces apoptosis in human pre-B acute lymphoblastic leukemia cells through inhibition of prosurvival signals.

Shabestari RM, Safa M, Alikarami F, Banan M, Kazemi A.

Biomed Pharmacother. 2017 Mar;87:274-279. doi: 10.1016/j.biopha.2016.12.070. Epub 2017 Jan 4.

PMID:
28063408
8.

Association Study of IL-4 -590 C/T and DDX39B -22 G/C Polymorphisms with the Risk of Late-Onset Alzheimer's Disease in Iranian Population.

Soosanabadi M, Bayat H, Kamali K, Saliminejad K, Banan M, Khorram Khorshid HR.

Curr Aging Sci. 2015;8(3):276-81.

PMID:
26265379
9.

A defect in the CLIP1 gene (CLIP-170) can cause autosomal recessive intellectual disability.

Larti F, Kahrizi K, Musante L, Hu H, Papari E, Fattahi Z, Bazazzadegan N, Liu Z, Banan M, Garshasbi M, Wienker TF, Hilger Ropers H, Galjart N, Najmabadi H.

Eur J Hum Genet. 2015 Mar;23(3):416. doi: 10.1038/ejhg.2014.152. No abstract available.

10.

Mutation screening of the Krüppel-like factor 1 gene using single-strand conformational polymorphism in a cohort of Iranian β-thalassemia patients.

Zaker-Kandjani B, Namdar-Aligoodarzi P, Azarkeivan A, Najmabadi H, Banan M.

Hemoglobin. 2015;39(1):24-9. doi: 10.3109/03630269.2014.991023. Epub 2015 Jan 13.

PMID:
25583416
11.

Chitosan nanoparticles for siRNA delivery: optimization of processing/formulation parameters.

Esmaeilzadeh Gharehdaghi E, Amani A, Khoshayand MR, Banan M, Esmaeilzadeh Gharehdaghi E, Amini MA, Faramarzi MA.

Nucleic Acid Ther. 2014 Dec;24(6):420-7. doi: 10.1089/nat.2014.0484.

12.

A defect in the CLIP1 gene (CLIP-170) can cause autosomal recessive intellectual disability.

Larti F, Kahrizi K, Musante L, Hu H, Papari E, Fattahi Z, Bazazzadegan N, Liu Z, Banan M, Garshasbi M, Wienker TF, Ropers HH, Galjart N, Najmabadi H.

Eur J Hum Genet. 2015 Mar;23(3):331-6. doi: 10.1038/ejhg.2014.13. Epub 2014 Feb 26. Erratum in: Eur J Hum Genet. 2015 Mar;23(3):416.

13.

Detection of HER2 status in breast cancer: comparison of current methods with MLPA and real-time RT-PCR.

Pazhoomand R, Keyhani E, Banan M, Najmabadi H, Khodadadi F, Iraniparast A, Feiz F, Majidzadeh K, Bahman I, Moghadam FA, Sobhani AM, Muhammadnejad A, Abedini SS, Behjati F.

Asian Pac J Cancer Prev. 2013;14(12):7621-8.

14.

Optimizing A Lipocomplex-Based Gene Transfer Method into HeLa Cell Line.

Asgharian A, Banan M, Najmabadi H.

Cell J. 2014 Winter;15(4):372-7. Epub 2013 Nov 20.

15.

Utility of the multivariate approach in predicting β-thalassemia intermedia or β-thalassemia major types In Iranian patients.

Banan M, Bayat H, Namdar-Aligoodarzi P, Azarkeivan A, Kamali K, Daneshmand P, Zaker-Kandjani B, Najmabadi H.

Hemoglobin. 2013;37(5):413-22. doi: 10.3109/03630269.2013.805418. Epub 2013 Jun 27.

PMID:
23805990
16.

Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond?

Banan M.

Ann Hematol. 2013 Mar;92(3):289-99. doi: 10.1007/s00277-012-1671-3. Epub 2013 Jan 15. Review.

PMID:
23318979
17.

The XmnI and BCL11A single nucleotide polymorphisms may help predict hydroxyurea response in Iranian β-thalassemia patients.

Banan M, Bayat H, Azarkeivan A, Mohammadparast S, Kamali K, Farashi S, Bayat N, Khani MH, Neishabury M, Najmabadi H.

Hemoglobin. 2012;36(4):371-80. doi: 10.3109/03630269.2012.691147. Epub 2012 Jun 11.

PMID:
22686296
18.

cAMP response element-binding protein 1 is required for hydroxyurea-mediated induction of γ-globin expression in K562 cells.

Banan M, Esmaeilzadeh-Gharehdaghi E, Nezami M, Deilami Z, Farashi S, Philipsen S, Esteghamat F, Pourfarzad F, Ali Imam AM, Najmabadi H.

Clin Exp Pharmacol Physiol. 2012 Jun;39(6):510-7. doi: 10.1111/j.1440-1681.2012.05702.x.

PMID:
22469229

Supplemental Content

Loading ...
Support Center